Abstract:
Composition cosmétique comprenant un composé multifonctionnel, composé et procédé de traitement cosmétique L'invention concerne une composition cosmétique comprenant au moins un composé de formule (I) : (Z)x-(L)w-(A)y dans laquelle : -x et y sont des entiers allant de 1 à 4; -w représente 0 ou 1; -Z représente un groupement choisi parmi : (Z); -L représente une chaîne hydrocarbonée en C1-C100, comportant éventuellement un ou plusieurs hétéroatomes; -A désigne Z ou bien est une entité apte à réagir avec les fonctions soufrées des matières kératiniques. L'invention concerne également les composés nouveaux, ainsi qu'un procédé de traitement cosmétique des matières kératiniques employant ladite composition, en particulier un procédé de conditionnement, mise en forme, renforcement et/ou réparation des cheveux.
Abstract:
The present invention provides convergent processes for preparing epothilones, desoxyepothilones, and analogues thereof. The present invention further provides novel compositions and methods for the treatment of cancer and additionally provides methods for the treatment of cancer which has developed a multi-drug phenotype.
Abstract:
A method is disclosed for making a conjugate of two molecules using a hydrazide thiol linker. In a particular working embodiment, an Fc-specifÊc antibody- enzyme conjugate is made using the method and demonstrated to provide exceptional staining sensitivity and specificity in immunohistochemical and in situ hybridization assays.
Abstract:
The invention relates to novel compounds of formula (I) wherein R, R and R have the designation cited in patent claim 1. Said compounds are inhibitors of the coagulation factors Xa and VIIa, and can be used to treat thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, intermittent claudication, tumours, tumour diseases and/or tumour metastases.
Abstract:
Compounds and methods for mitigating neurodegeneration, effecting neuroprotection and/or effecting cognition enhancement in a subject are described. Neurological or cognitive conditions are treated by administering to a subject an effective amount of a therapeutic compound comprising a nitrate ester, or a pharmaceutically acceptable salt or ester thereof.
Abstract:
The invention relates to phenoxyacetic acid derivatives of formula (I), wherein R1, R2, Xn and A are as defined in the description, A represents a halogen atom, hydroxy, OR3, S(O)kR3, or a group of formula (A-1) or (A-2), wherein R3-R5 and k have the meanings given in the description, and to their use as herbicides.
Abstract translation:本发明涉及式(I)的苯氧基乙酸衍生物,其中R1,R2,Xn和A如说明书中所定义,A表示卤素原子,羟基,OR 3,S(O)k R 3或式 A-1)或(A-2),其中R3-R5和k具有说明书中给出的含义,以及它们作为除草剂的用途。
Abstract:
The present invention relates to Fluoromalonyl Halfthioesters (F-MAHTs) of formula (I), wherein R 1 represents hydrogen, halogen, an optionally substituted alkyl group, an optionally substituted cycloalkyl group, an optionally substituted aryl group; and R 2 represents an optionally substituted aryl group, an optionally substituted cycloalkyl group, an optionally substituted heteroaryl group, an optionally substituted heterocyclyl group; an optionally substituted alkyl group. The invention further relates to their synthesis and to their use, particularly as masked fluoroacetates in the preparation of pharmaceutical active ingredients.
Abstract:
This invention relates to a process for the preparation of thioacetates addition of thioacetic acid or a salt thereof on alpha -, beta -, or gamma -unsaturated alcohols, carbonyl compounds or cyclic or acyclic alkenes or by nucleophilic substitution of the hydroxyl group or a halogen with S-acetyl group in food-grade organic solvent. These thioacetates can be used as enhancers or intensifiers of flavour in food products or as aromas in compounded flavours. A number of individual compounds is also claimed.
Abstract:
The present invention provides convergent processes for preparing epothilones, desoxyepothilones, and analogues thereof. The present invention further provides novel compositions and methods for the treatment of cancer and additionally provides methods for the treatment of cancer which has developed a multi-drug phenotype.